SCHEMBL6861099

SCHEMBL6861099

CC(C)(C)OC(=O)N1C(=O)C(Br)=C[C@@H]1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 3/20 0.35
KLK7 P49862 6/20 0.35
FKBP1A P62942 1/20 0.33
DUT P33316 1/20 0.33
GPR119 Q8TDV5 3/20 0.33
KLK5 Q9Y337 5/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
ELANE P08246 1/20 0.33
KMT2A Q03164 1/20 0.32
PRSS1 P07477 2/20 0.32
PRSS2 P07478 2/20 0.32
PRSS3 P35030 2/20 0.32
GAA P10253 1/20 0.32
THRB P10828 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
SMARCA2 P51531 1/20 0.32
SMARCA4 P51532 1/20 0.32
PBRM1 Q86U86 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6868570 0.82 HTT (0.39) GPR119HPGDKMT2A
SCHEMBL960356 0.78 TOP2A (0.34) TOP2AKLK7FKBP1ADUTGPR119
SCHEMBL2504329 0.78 TOP2A (0.34) TOP2AKLK7FKBP1ADUTGPR119
SCHEMBL190828 0.78 TOP2A (0.34) TOP2AKLK7FKBP1ADUTGPR119
SCHEMBL6861270 0.77 PRMT5 (0.43) KLK7
SCHEMBL8222384 0.77 PRMT5 (0.43) KLK7
SCHEMBL8119034 0.74 RORC (0.37) TOP2AGPR119KMT2A
SCHEMBL352414 0.74 CHRM2 (0.34) TOP2AKLK7FKBP1ADUTGPR119
SCHEMBL16689223 0.73 CHRM2 (0.35) TOP2AFKBP1ADUTKMT2ASMN1; SMN2
SCHEMBL10025390 0.73 CHRM2 (0.35) TOP2AFKBP1ADUTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004578-B1 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives PFIZER PROD INC (US) 2004-02-25 EP disclosed
US-6114361-A INHIBITORS OF MATRIX METALLOPROTEINASES AND REPROLYSIN; ADMINISTERING TO TREAT CONDITIONS WHICH CAN BE TREATED BY THE INHIBITION OF THESE ENZYMES PFIZER INC. (US) 2000-09-05 US disclosed
EP-1004578-A2 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives Pfizer Products Inc. (US) 2000-05-31 EP disclosed